why did fda stop tirzepatide Is Approved? Speak up and share your

Because of the GI effects, caution is advised in patients with severe gastroparesis (e.g., long-standing diabetic gastroparesis) GLP-1 RAs can worsen gastric emptying delays and are generally not recommended in that scenario

How should research peptides be stored to maintain purity

It is possible, as the authors imply, that there might be some other anti-inflammatory benefits that are having an outcome on cancer risk reduction. Wolff-Sagy shared that future work would involve looking at other cohort studies, expanding the demographics and timeframe of the study, and digging into the molecular mechanisms behind GLP-1 treatments

A similar effect was described in association with tirzepatide, a GIP-R/GLP-1R co-agonist [24]

KPV (Lysine-Proline-Valine) Research Focus: Examined for its potent modulation of inflammatory signaling pathways and immune cell responses